COVID-19 Drugs: Researchers from the University of Bari Aldo Moro-Italy and the University Campus Bio-Medico of Rome have in a new study found that the diuretic drug Ethacrynic Acid could be repurposed to treat COVID-19.
The research findings are published in the peer reviewed journal: Viruses https://www.mdpi.com/1999-4915/13/1/106/htm
The SARS-CoV-2 coronavirus, the causative ...
COVID-19 Drugs: A new study by researchers from University of Birmingham-UK, Keele University-UK, San Raffaele Scientific Institute-Italy, University of Copenhagen-Denmark and the University of Liverpool-UK demonstrates that the drug called Fenofibrate exhibits antiviral properties against the SARS-CoV- coronavirus and could be repurposed to treat COVID-19.
Fenofibrate, ...
Source: Ivermectin-COVID-19 Jan 12, 2021 16 days ago
Ivermectin-COVID-19: Indian researchers from the All India Institute of Medical Sciences have conducted a a double-blind, randomized, placebo-controlled clinical trial that demonstrated the efficacy of Ivermectin to treat COVID-19 disease. The clinical trial showed that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate COVID-19 patients.
Ivermectin is currently being used ...
Source: Thailand Medical News Jan 08, 2021 20 days ago
A new international study lead by medical researchers from Perelman School of Medicine at the University of Pennsylvania has found that common medications used to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19. This study findings provides relief to many as during the initial phases of the COVID-19 pandemic, there were speculations that certain blood pr...
Pharma News: Florida based AzurRx BioPharma, a company specializing in the development of non-systemic therapies for gastrointestinal (GI) diseases has announced that it has signed an exclusive worldwide licensing agreement with First Wave Bio, Inc for the use of their patented and proprietary oral and rectal formulations of niclosamide for the treatment of immune checkpoint inhibitor-as...
COVID-19 Drugs: The second wave of the COVID-19 pandemic is currently taking a toll on numerous countries around the world with daily global infection rates now surpassing 700,000 and daily COVID-19 deaths now exceeding 13,000 (On December 16th new records were reported with more than 725,950 COVID-19 infections in 24 hours and 13,558 COVID-19 deaths).
As of Friday, (9am Bangkok time), th...
Source: Ivermectin and COVID-19 Dec 13, 2020 2 months ago
Ivermectin to treat COVID-19 in various stages of the disease is turning to be a more viable and proven option despite strong opposition from groups with vested interest in America and Europe.\
This time, a double blind, placebo- controlled randomized clinical trial tested the efficacy of the drug to treat mild conditions of the disease and to see how it prevents high viral loads, how it prevente...
Source: COVID-19 Antivirals Dec 05, 2020 2 months ago
COVID-19 Antivirals: The interim WHO Solidarity Trial results confirms that antivirals like remdesivir, lopinavir, interferon and hydroxychloroquine seem to have little to no effect on mortality for hospitalized patients with COVID-19.
The trial randomly assigned hospitalized patients with Covid-19 equally between one of the trial drug regimens that was locally available and open control ...
Source: Supplements, Herbs and Repurposed Drugs For COVID-19 Dec 04, 2020 2 months ago
This simple guide to COVID-19 supplements, repurposed drugs and herbs that can help one with the COVID-19 is basically to help all around the world especially our readers in America, UK, the rest Of Europe, South America and India that has been badly affected by the COVID-19 pandemic and is going through a rough crisis in their countries.
These are based on past articles that Thailand Medical N...
Molnupiravir: As of the last count on Friday morning (4th December), sadly more than 276,120 Americans have died from the COVID-19 disease so far and more than 14.2 million COVID-19 infection cases were logged in the country. These figures are expected to rise exponentially in the next few months despite having so many ‘experts’ in the country.
It was reported that resea...
Source: Thailand Medical News Nov 30, 2020 2 months ago
Despite appealing so many times and despite having a huge readership base, we had only 6 kind individuals who ever responded to our calls for help and support.
We desperately need funds to sustain this website and aso to continue with our various research especially for our herbal research for COVID-19 and our therapeutic teas for COVID-19. https://www.thailandmedical.news/news/new-therape...
Ivermectin-COVID-19: Finally the results of a randomized trial has emerged to show the effectiveness of Ivermectin to treat COVID-19 despite numerous attempts by various big American and European pharmaceutical companies and their governments to try to suppress Ivermectin research due to greed and financial scams.
The clinical trial study was led by Iranian researchers from Qazvin university of m...
Source: Coronavirus News Nov 27, 2020 2 months ago
Coronavirus News: French researchers in a new multicenter study have found a lower or equal risk of fatal COVID-19 in hypertensive patients, depending on the type of medication they are on.
The study finding confirms earlier recommendations that antihypertensives should be continued in these patients before and during infection with SARS-CoV-2, the viral agent that causes COVID-19.
...
American COVID-19 Scams: The Trump controlled U.S FDA, a regulatory agency that no longer has any credibility has suffered yet another blow as ethical medical professionals are advocating against the use of the overpriced drug bamlanivimab (Eli Lilly) that was granted emergency use authorization (EUA) by the U.S. FDA on the November 10th for use in ambulatory patients with mild to moderate COVID-1...
COVID-19 Scams: More emerging news coming out from the land of COVID-19 Scams-America. After the hydrochloroquinone, convalescent plasma and remdesivir sagas, we have the Eli lily monoclonal drug and now the Regeneron’s antibody cocktail drug being granted emergency authorization or EUA status to treat COVID-19. It was already expected news as many were sure that Trump has to oblige his...
Source: COVID-19 Breakthroughs Nov 20, 2020 2 months ago
COVID-19 Breakthroughs: A new breakthrough study led by researchers from St. Jude Children's Research Hospital-Memphis along with scientist from University of Tennessee Health Science Center have discovered that inflammation in COVID-19 patients were not just caused by cytokine storms per se or even just by bradykinin storms but rather were triggered by what is known as PANoptosis.
PA...
Source: COVID-19 Intranasals Nov 20, 2020 2 months ago
COVID-19 Intranasals: Scientists from the University of Birmingham have developed a nasal spray that can provide effective protection against the SARS-CoV-2 coronavirus by using materials already cleared for use in humans.
Airborne pathogens pose high risks in terms of both contraction and transmission within the respiratory pathways, in particular the nasal region. Although knowledge of ...
COVID-19 Scams: Finally the world is seeing more day by day the scams perpetrated by American entities including the NIH, CDC, FDA, the Trump Administration and individuals like Dr Anthony Fauci, billionaires like Tom Cahill and politicians like Nick Ayers and Mike Spence.
One of the biggest scams that is coming to light is remdesivir, an overpriced drug that had no efficacy against COVID...
COVID-19 Drugs: A new study by Taiwanese researchers from Chang Gung University, Kaohsiung Medical University, Chang Gung Memorial Hospital, Ming Chi University of Technology and Puxin Fengze Chinese Medicine Clinic have found that strategies using drugs and therapeutics to target neutrophils help to reduce and treat respiratory distress syndrome (ARDS) in severe COVID-19 patients.
...
Source: COVID-19 Prophylaxis Nov 09, 2020 3 months ago
COVID-19 Prophylaxis: A recent study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of the drug ivermectin served as a prophylaxis that resulted in a 73% reduction in COVID-19 infection.
In the study that was also propelled by Thailand Medical News research initiatives, ivermectin prophylaxis was taken by 77 controls and ...
Source: COVID-19 Mortality Nov 05, 2020 3 months ago
COVID-19 Mortality risk was found to be reduced by 22% to 25% in individuals taking statins according to a Spanish study.
The retrospective observational study involved patients taking statins who were 11 years older and had significantly more comorbidities than patients who were not taking statins. A genetic matching (GM) procedure was performed prior to analysis of the mortality risk. ...
COVID-19 Drugs: Researchers from the University of South Australia, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS)-Italy and University of Campania-Italy in a new international study propose that beta-blockers could potentially be used to treat COVID-19.
COVID-19 disease which has now rapidly spread around the globe causing severe pneumonia is often linked to Acute Respir...
COVID-19 Drugs: With the current COVID-19 pandemic fast escalating and no effective drugs to date, researchers around the world are desperately trying to find suitable drug candidates to further explore their efficacy against the SARS-CoV-2 coronavirus. In two separate studies, two possible drug candidates that demonstrated to inhibit the SARS-CoV-2 virus were identified, one being 5-Amino Levulin...
Source: COVID-19-Antibodies Oct 30, 2020 3 months ago
COVID-19-Antibodies: The independent data monitoring committee (IDMC) has recommended that Regeneron ‘s clinical trial of its antibody treatment called REGN-COV2 for severe COVID-19 patients needing oxygen or who are on ventilators be suspended with immediate effect. The decision was made in the last 24 hours and Regeneron was legally obliged to comply immediately.
On early Fr...
COVID-19 Drugs: Researchers from Yale University School of Medicine in a new study exploring the inhibitory effects of the drug merofloxacin on frameshifting during SARS-CoV-2 replication have reported positive results in vitro studies. The study findings are an important proof-of-concept that supports the potential for targeting −1 PRF (programmed −1 ribosomal frameshifting) as a...
Source: Aspirin-COVID-19 Oct 24, 2020 3 months ago
Aspirin-COVID-19: A new study led by researchers from University of Maryland School of Medicine (UMSOM) shows that hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin.
Importantly, aspirin takers were less likely to be placed...
Source: COVID-19 -Dexamethasone Oct 24, 2020 3 months ago
COVID-19 -Dexamethasone: A new study led by researchers from University of Virginia-U.S. along with scientist from Polish Academy of Sciences-Poland, Poznan University of Technology-Poland, Medical University of Bialystok-Poland and University of South Carolina-U.S. has discovered a about how the human body transports dexamethasone, a drug that can increase the survival chances of patients wi...
America Latest: America is facing a major health crisis with the Trump Administration in power and the degree of incompetency, greed and corruption in play. Already America has a total of more than 8.4 million confirmed COVID-19 cases with realistic figures expected to be much higher due to under-reporting in Republican controlled states and lack of testing among asymptomatic cases and as of today...
Drugs-COVID-19: Fortunately another COVID-19 drug scam is being prevented after the remdesivir saga thanks to honest and credible researchers that cannot be manipulated by money. The US FDA under the Trump administration and Trump’s family and cronies has done even damage with hydrochloroquine and remdesivir issues with many American lives lost and hopefully after Trump loses this elections,...
COVID-19 Drugs: Ensifentrine a drug originally developed by UK based pharmaceutical cum biotech company Verona Pharma to treat chronic obstructive pulmonary disease or COPD could be a new treatment option for hospitalized COVID-19 patients. According to research this dual bronchodilator and anti-inflammatory drug be safe and effective in COVID-19 patients experiencing the debilitating effects of s...
Remdesivir: Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
The study results of the trial are under review for publi...
Source: COVID-19 Intranasal Drugs Oct 15, 2020 3 months ago
COVID-19 Intranasal Drugs: North Carolina based clinical-stage biotechnology company Novan, Inc. that specializes in various nitric oxide based therapeutics has announced that its vitro studies involving its NITRICIL™ platform technology that uses berdazimer sodium has demonstrated antiviral effects against the SARS-CoV-2 coronavirus tha causes the COVID-19 disease.
Berdaz...
Source: COVID-19 Therapeutics Oct 13, 2020 4 months ago
COVID-19 Therapeutics: According to new research carried out at the University of St Andrews-Scotland, a new inhalation treatment protocol and drug involving synthetic interferons to prevent the spread of COVID-19 is potentially far more effective than currently existing versions of interferons or inhalation protocols.
The Scottish biotech company, ILC Therapeutics based in Newhouse...
COVID-19 Drugs: A new vivo study involving animal models by researchers from Hong Kong University show that the cheap stomach ulcer drug ranitidine bismuth citrate (Tritec) is able to inhibit the SARS-CoV-2 coronavirus.
The study team on Monday announced that the anti-microbial drug used to treat stomach ulcers and bacterial infections has shown promise in combatting the coronavirus...
COVID-19 Help: While tens of thousands are getting infected daily and thousands are dying each day, millions elsewhere are worried and are trying to find ways to help themselves and their loved ones and the only thing that stupid health authorities and incompetent corrupted governments around the world are doing are giving false hopes by an anticipated COVID-19 vaccine that many think will solve t...
COVID-19 Scams? As anticipated, Eli Lily and Regeneron have applied for emergency approval for their laboratory -produced antibodies against COVID-19 and Donald Trump aka ‘Loony Dump Trump’ has signaled his strong presidential backing based on the fact he was treated with them. (There no proof if he was really infected and the whole thing could have been elaborately staged or is ...
Source: COVID-19 Treatments Oct 06, 2020 4 months ago
COVID-19 Treatments: Australian researchers from The University of Newcastle, Hunter Medical Research Institute-New South Wales, University of Technology Sydney and Chinese scientists from Jilin University-Changchun have in a new study confirmed that the SARS-CoV-2 spike glycoprotein subunit 1 can induce a pro-inflammatory signaling pathway (leading to cytokines deployment and epithelial...
Source: COVID-19 Breakthrough Oct 06, 2020 4 months ago
COVID-19 Breakthrough: Canadian researchers have made a major breakthrough during a study on UPR or unfolded protein response during coronaviruses viral replication leading them to a discovery of thiopurines to stop the viral replication of human coronaviruses including SARS-CoV-2. This breakthrough with further research could lead to a new and effective broad-spectrum therapeutic antiviral that c...
COVID-19 Drugs: An urgent immediate safety review of the drug Remdesivir has been called by the European Medicines Agency after numerous COVID-19 patients taking the drug have developed serious kidney problems.
The EU regulator issued a statement a few hours ago saying that it seemed that remdesivir was causing the "acute kidney injury," and that the issue "warrants further...
Drugs-COVID-19: Anti-tumour necrosis factor (anti-TNF) drugs or TNF inhibitors are now being explored by numerous researchers to treat COVID-19 after recent studies of patients with COVID-19 have shown that patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital. The same was not observed for patients taking other ...
Source: COVID-19 Intranasal Drugs Sep 30, 2020 4 months ago
COVID-19 Intranasal Drugs: Researchers from the National Infection Service-UK, Ena Respiratory, Melbourne-Australia, The University of Melbourne-Australia, University of Newcastle-Australia and Oxford University-UK are exploring the usage of TLR2/6 Agonist INNA-051 as an intranasal prophylaxis against COVID-19.
To date their vivo studies involving animal models showed that the TLR2 agonis...
Source: COVID-19 Research Sep 30, 2020 4 months ago
COVID-19 Research: A study led by researchers from the University of Cincinnati along with scientists from University of Duisburg-Germany, the German Primate Center and Saarland University-Germany have discovered that sphingosine, a naturally occurring lipid in the human body could be used as a potential treatment for COVID-19 as prevents binding of SARS-CoV-2 spike to its cellular receptor ...
Source: COVID-19-Povidone-Iodine Sep 27, 2020 4 months ago
COVID-19- Povidone-Iodine: A study led by researchers from the University of Connecticut School of Medicine-Farmington along with experts from The Institute for Antiviral Research at Utah State University, Veloce BioPharma-Florida, ProHealth-Farmington and Ocean Ophthalmology-Florida has demonstrated that an antiseptic nasal spray containing povidone-iodine may help curb transmission of the SARS-C...
Source: Metformin-COVID-19 Sep 26, 2020 4 months ago
Metformin-COVID-19: A few past research studies the last few months has shown the possibility of using metformin, the common cheap and easily available diabetes drug being used for COVID-19 treatments as it was found to reduce severity and mortality rates in COVID-19 patients.
In one study, the researchers found that among more than 600 patients with diabetes and COVID-19, use of metformin ...
Source: COVID-19 Treatments Sep 24, 2020 4 months ago
COVID-19 Treatments: Two new studies by researchers from the University of California-San Diego show that statin usage is linked to a lower risk of developing COVID-19 severity and that removing cholesterol from cell membranes prevents the virus from getting into these cells.
Furthermore there is some biologic plausibility for a protective role of statins in COVID-19 through known anti-in...
Source: COVID-19 Treatments Sep 22, 2020 4 months ago
COVID-19 Treatments: Medical researchers and physicians are now trying interrupt the SARS-CoV-2 coronavirus before it gets into the lungs and the rest of the body and starts ravaging the body, targeting not only the lungs, heart and blood vessels but even the cerebrospinal fluids, the brain, the kidneys, the gastroenterological tract , the male testis to even the immune system itself.
The...
Source: COVID-19 Scams-Russia Sep 22, 2020 4 months ago
COVID-19 Scams: It was announced that Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies throughout the country as soon as next week, the company said on Friday.
The drug’s approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avi...
COVID-19 Scams: Of all the stupidity and craziness which not many people are questioning (the intelligence levels in America has sunk to its lowest!) is the new American standard for drug approvals set by the US FDA under the Trump administration in which as long you can demonstrate somehow by whatever means that a drug is able to shorten hospitalization stays, Voila! You get approved and you can ...
Drugs-COVID-19: Spanish researchers from the Department of Cell Biology at the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have identified 4-Phenylbutiric acid or 4-PBA as a possible drug candidate to treat the various inflammatory and immune issues resulting from the SARS-CoV-2 coronavirus infection that causes COVID-19 disease.
The s...
Source: Coronavirus Supplements Sep 18, 2020 4 months ago
Coronavirus Supplements: Researchers from the University of Nebraska Medical Center and Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring have demonstrated in vitro studies that bromelain extracted from pineapples is able to inhibit the SARS-CoV-2 coronavirus in Vero E6 cells via a multitude of ways.
The study findings are published on a preprint server and are...
Source: Coronavirus Antivirals Sep 17, 2020 4 months ago
Coronavirus Antivirals: Researchers from University of Chinese Academy of Sciences, Shanghai-China have identified the antibiotic Ceftazidime as possible antiviral candidate to inhibit SARS-CoV-2 coronavirus and treat the COVID-19 disease.
The research findings were published on a preprint server and have yet to be peer reviewed.
https://www.biorxiv.org/content/10.1101/2020.09.14.295956v1
...
Source: COVID-19 Immunotherapy Sep 17, 2020 4 months ago
COVID-19 Immunotherapy: Researchers from Corvus Pharmaceuticals Inc-California, Temple University-Philadelphia and Icahn School of Medicine at Mount Sinai-New York in a phase 1 clinical trial have demonstrated that using a Inhibitor Of CD73 Enzymatic Activity called CPI-006, the researchers were able to induce the effective B Cell and Humoral response to SARS-CoV-2 infection in COVID-19 patients e...
COVID-19 Meds: A new vitro study led by Austrian researchers from the University of Vienna has demonstrated that the nasal antihistamine Azelastine was able to inhibit SARS-CoV-2 infections in assays using reconstituted human nasal tissue and Vero E6 monkey kidney epithelial cells. The study team says that Azalastine is a prospective drug candidate that could be used to reduce viral transmission i...
COVID-19 Drugs: Azithromycin, a commonly-prescribed antibiotic that also is being investigated as a potential treatment for COVID-19 according to a new study by researchers from the University of Illinois Chicago, by itself is not associated with an increase in cardiac events; however, if taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increa...
COVID-19 Drugs: Researchers from the University of Pittsburgh School of Medicine claim to have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 coronavirus.
The research findings were published in the journal: Cell https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%...
.jpg)
